1. Home
  2. AMBQ vs LXRX Comparison

AMBQ vs LXRX Comparison

Compare AMBQ & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBQ
  • LXRX
  • Stock Information
  • Founded
  • AMBQ 2010
  • LXRX 1995
  • Country
  • AMBQ United States
  • LXRX United States
  • Employees
  • AMBQ N/A
  • LXRX N/A
  • Industry
  • AMBQ Semiconductors
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBQ Technology
  • LXRX Health Care
  • Exchange
  • AMBQ Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • AMBQ 673.1M
  • LXRX 552.4M
  • IPO Year
  • AMBQ 2025
  • LXRX 2000
  • Fundamental
  • Price
  • AMBQ $29.83
  • LXRX $1.40
  • Analyst Decision
  • AMBQ Buy
  • LXRX Buy
  • Analyst Count
  • AMBQ 4
  • LXRX 5
  • Target Price
  • AMBQ $41.75
  • LXRX $3.23
  • AVG Volume (30 Days)
  • AMBQ 145.4K
  • LXRX 2.6M
  • Earning Date
  • AMBQ 11-06-2025
  • LXRX 11-11-2025
  • Dividend Yield
  • AMBQ N/A
  • LXRX N/A
  • EPS Growth
  • AMBQ N/A
  • LXRX N/A
  • EPS
  • AMBQ N/A
  • LXRX N/A
  • Revenue
  • AMBQ $74,210,000.00
  • LXRX $58,432,000.00
  • Revenue This Year
  • AMBQ N/A
  • LXRX $66.55
  • Revenue Next Year
  • AMBQ $25.34
  • LXRX N/A
  • P/E Ratio
  • AMBQ N/A
  • LXRX N/A
  • Revenue Growth
  • AMBQ N/A
  • LXRX 1504.83
  • 52 Week Low
  • AMBQ $28.61
  • LXRX $0.28
  • 52 Week High
  • AMBQ $51.76
  • LXRX $2.08
  • Technical
  • Relative Strength Index (RSI)
  • AMBQ N/A
  • LXRX 49.51
  • Support Level
  • AMBQ N/A
  • LXRX $1.36
  • Resistance Level
  • AMBQ N/A
  • LXRX $1.48
  • Average True Range (ATR)
  • AMBQ 0.00
  • LXRX 0.09
  • MACD
  • AMBQ 0.00
  • LXRX -0.02
  • Stochastic Oscillator
  • AMBQ 0.00
  • LXRX 8.33

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: